Mapinastine

Anti-TACO1 translational activator of mitochondrially encode

General description This gene encodes one of the subunits of the tRNA splicing endonuclease. This endonuclease catalyzes the first step in RNA splicing which is the removal of introns.

Specificity Tyrosinase Immunogen Purified recombinant Tyrosinase corresponding to residues 5-456 of human Tyrosinase Application Not recommended for Immunoprecipitation Research Category Neuroscience Research Sub Category Neurofilament &amp:

InformationAtaluren (PTC124) Ataluren (PTC124) selectively induces ribosomal read-through of premature but not normal termination codons, with EC50 of 0.1 μM in HEK293 cells, may provide treatment for genetic disorders caused by nonsense mutations

BLOT-QuickBlocker™

DL -buthionine- SR -sulfoximine (BSO) is an amino acid analogue, which acts as an inhibitor of &#947-glutamylcysteine synthetase. BSO increases the sensitivity of Trypanosoma cruzi to antiparasitic drugs, such as nifurtimox or benznidazole.

DL -buthionine- SR -sulfoximine (BSO) is an amino acid analogue, which acts as an inhibitor of &#947-glutamylcysteine synthetase. BSO increases the sensitivity of Trypanosoma cruzi to antiparasitic drugs, such as nifurtimox or benznidazole.

DL -buthionine- SR -sulfoximine (BSO) is an amino acid analogue, which acts as an inhibitor of &#947-glutamylcysteine synthetase. BSO increases the sensitivity of Trypanosoma cruzi to antiparasitic drugs, such as nifurtimox or benznidazole.

A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJD3 and UTX (IC50s = 18 and 56 &microM, respectively as measured by mass spectrometry IC50 = 60 nM in JMJD3 antibody-based assays).

A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJD3 and UTX (IC50s = 18 and 56 &microM, respectively as measured by mass spectrometry IC50 = 60 nM in JMJD3 antibody-based assays).

A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJD3 and UTX (IC50s = 18 and 56 &microM, respectively as measured by mass spectrometry IC50 = 60 nM in JMJD3 antibody-based assays).

A selective, ATP-competitive inhibitor of the serine/threonine kinase, glycogen synthase kinase 3&beta (Ki = 38 nM IC₅₀ = 104 nM) demonstrates neuroprotective effects by inhibiting tau phosphorylation (IC₅₀ = 2.7 &muM) at a